目的 分析吉林大學(xué)第一醫(yī)院抗腫瘤中藥注射劑的應(yīng)用情況及變化趨勢(shì),為臨床合理用藥提供參考。方法 調(diào)取2011-2014年吉林大學(xué)第一醫(yī)院抗腫瘤中藥注射劑的使用數(shù)據(jù),采用用藥頻度(DDDs)、日均費(fèi)用(DDC)及藥物利用指數(shù)(DUI)等藥物利用指標(biāo)進(jìn)行回顧性分析。結(jié)果 2011-2014年抗腫瘤中藥注射劑的用藥金額呈逐年上升趨勢(shì),品種基本穩(wěn)定;4年來(lái)艾迪注射液的DDDs居首位,DDC基本穩(wěn)定不變,并且DDC值均較高;消癌平注射液的DUI居首位;抗腫瘤中藥注射劑的不良反應(yīng)發(fā)生較少。結(jié)論 吉林大學(xué)第一醫(yī)院抗腫瘤中藥注射劑的應(yīng)用基本合理,呈不斷增長(zhǎng)趨勢(shì),應(yīng)加強(qiáng)監(jiān)管,保證合理、安全使用。

Objective To analyze utilization and trend of anti-tumor traditional Chinese medicine (TCM) injections in the First Hospital of Jilin University, to provide reference for clinical rational use. Methods The utilization of anti-tumor TCM injections in the First Hospital of Jilin University from 2011 to 2014 was selected, and defined daily doses (DDDs), daily drug cost (DDC), and drug utility index (DUI) were analyzed statistically. Results From 2011 to 2014, the consumption sum of anti-tumor TCM Injections increased year by year. The types of anti-tumor TCM injections were stable. Aidi Injection took the lead in terms of DDDs over the 4 years. DDC was stable and high. Xiaoaiping Injection took the lead in terms of DUI over the 4 years. There were less adverse reactions in anti-tumor TCM injections. Conclusion The utilization of anti-tumor TCM injections in the First Hospital of Jilin University is reasonable basically, and increases year by year. Supervision on rational use of anti-tumor TCM injections should be strengthened to ensure rational and safe use of anti-tumor TCM injections.